Chicago Trust’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Hold
16,700
0.09% 217
2026
Q1
$412K Hold
16,700
0.07% 264
2025
Q4
$282K Hold
16,700
0.04% 328
2025
Q3
$363K Hold
16,700
0.05% 307
2025
Q2
$238K Hold
16,700
0.03% 366
2025
Q1
$217K Hold
16,700
0.04% 342
2024
Q4
$222K Hold
16,700
0.04% 322
2024
Q3
$100K Hold
16,700
0.02% 374
2024
Q2
$54.9K Hold
16,700
0.01% 318
2024
Q1
$62.6K Hold
16,700
0.01% 287
2023
Q4
$73.1K Hold
16,700
0.02% 279
2023
Q3
$69.6K Hold
16,700
0.02% 279
2023
Q2
$58.3K Hold
16,700
0.01% 302
2023
Q1
$64.3K Hold
16,700
0.02% 301
2022
Q4
$47K Hold
16,700
0.01% 301
2022
Q3
$35K Hold
16,700
0.01% 296
2022
Q2
$44K Hold
16,700
0.01% 299
2022
Q1
$73K Hold
16,700
0.02% 328
2021
Q4
$72K Hold
16,700
0.01% 338
2021
Q3
$84K Buy
+16,700
New +$86.9K 0.02% 326

Other funds holding ETON

Chicago Trust's ETON Position: Q2 2026 in Review

Chicago Trust held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 16,700 shares worth $605K. The position accounts for 0.09% of the portfolio, ranked #217.

Chicago Trust first reported a position in ETON in Q3 2021 and has held it in 20 quarters since. 9 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Chicago Trust held 16,700 shares of Eton Pharmaceutcials worth $605K as of Q2 2026.
  • Chicago Trust left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up 0.09% of Chicago Trust's portfolio in Q2 2026, its #217 holding.
  • Chicago Trust first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 20 quarters since.
  • 9 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.